RecruitingRecruiting
Sleep and Arterial Function in Hypertensive Patients With Poor Sleep Quality
NCT07789535 · Unidade Local de Saúde do Alto Ave, EPE
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Impact of Sleep on Arterial Function, Psychological and Cognitive Complaints in Hypertensive Patients With Poor Sleep Quality
About this study
Background: Poor sleep quality is associated with increased arterial stiffness, depression, and cognitive decline, all of which contribute to cardiovascular risk in hypertensive patients. This trial tests whether improving sleep through CBT-I can attenuate arterial dysfunction and psychological/cognitive burden.
Design: Prospective, single-centre, parallel-group randomised controlled trial with 1:1 allocation, conducted at the Hypertension and Psychiatry Outpatient Clinics of the Unidade Local de Saude Alto Ave (ULSAAVE).
Intervention: CBT-I delivered in four weekly 60-minute sessions (sleep hygiene, stimulus control, relaxation techniques), adapted for participants with mild obstructive sleep apnea or comorbid insomnia and sleep apnea (COMISA).
Comparator: Passive sleep education (informational leaflets plus non-interactive follow-up calls); control participants are offered CBT-I after study completion.
Randomisation and blinding: Computer-generated block randomisation (blocks of 4-6), 1:1 allocation, with allocation concealment via sequentially numbered, opaque, sealed envelopes managed by a third party. Outcome assessors and data analysts are blinded; participants are partially blinded (control presented as an educational intervention).
Sample size: 234 participants (117 per group), accounting for 20% attrition, powered (80%, alpha 0.05) to detect a 0.4 m/s between-group difference in pulse wave velocity at 12 months.
Analysis: Linear mixed-effects models for repeated measures (time as fixed effect, participant as random effect, group as factor), with baseline apnea-hypopnea index included as a covariate.
Eligibility criteria
Inclusion Criteria:
* Adults aged 18 to 70 years
* Controlled hypertension
* Poor baseline sleep quality (sleep efficiency \<=85% assessed via actigraphy or type II polysomnography)
* Capable of providing informed consent
* Participants with mild obstructive sleep apnea (apnea-hypopnea index 5-14.9/h on type II polysomnography) who do not meet criteria for CPAP/PAP therapy are eligible
Exclusion Criteria:
* Severe cardiovascular disease (e.g., acute myocardial infarction or stroke)
* Severe neurological diseases
* Moderate-to-severe obstructive sleep apnea (AHI \>=15/h) or any obstructive sleep apnea with an indication for CPAP/PAP therapy
* Central disorders of hypersomnolence
* Intellectual disability
* Pregnancy
Study design
Enrollment target: 234 participants
Allocation: randomized
Masking: double
Age groups: adult, older_adult
Timeline
Starts: 2026-05-18
Estimated completion: 2030-03
Last updated: 2026-08-27
Interventions
Behavioral: Behavioral: Cognitive-Behavioural Therapy for Insomnia (CBT-I)Behavioral: Passive sleep education
Primary outcomes
- • Change from baseline in pulse wave velocity (PWV) (Baseline, 1 month, 6 months, and 12 months)
- • Change from baseline in central arterial pressure (CAP) (Baseline, 1 month, 6 months, and 12 months)
Sponsor
Unidade Local de Saúde do Alto Ave, EPE · other
Contacts & investigators
ContactSofia Gomes, MD · contact · 3603@ulsaave.min-saude.pt · + 351 253540330
InvestigatorSofia Gomes, MD · principal_investigator, Unidade Local de Saúde do Alto Ave
InvestigatorPedro Cunha, PhD · study_director, Unidade Local de Saúde do Alto Ave
All locations (1)
Unidade Local de Saúde do Alto Ave - Hospital Senhora da OliveiraRecruiting
Guimarães, Braga District, Portugal